Evidence map›Paper›PMID 35053322›Full record

ArticleCells2022

CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle.

Agnieszka U Błachnio-Zabielska, Kamila Roszczyc-Owsiejczuk, Monika Imierska, Karolina Pogodzińska, Paweł Rogalski, Jarosław Daniluk, Piotr Zabielski

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Agnieszka U Błachnio-ZabielskaDepartment of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, Mickiewicza 2c, 15-089 Bialystok, Poland.ORCID 0000-0002-8055-0576
Kamila Roszczyc-OwsiejczukDepartment of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, Mickiewicza 2c, 15-089 Bialystok, Poland.
Monika ImierskaDepartment of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, Mickiewicza 2c, 15-089 Bialystok, Poland.
Karolina PogodzińskaDepartment of Hygiene, Epidemiology and Metabolic Disorders, Medical University of Bialystok, Mickiewicza 2c, 15-089 Bialystok, Poland.
Paweł RogalskiDepartment of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland.
Jarosław DanilukDepartment of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0002-0787-1461
Piotr ZabielskiDepartment of Medical Biology, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0002-4901-5217
Medical University of Białystok · PL

Funding

Foundation for Polish Science TEAM/2016-1/2
6 · The paper itself

Abstract

Skeletal muscle is perceived as a major tissue in glucose and lipid metabolism. High fat diet (HFD) lead to the accumulation of intramuscular lipids, including: long chain acyl-CoA, diacylglycerols, and ceramides. Ceramides are considered to be one of the most important lipid groups in the generation of skeletal muscle insulin resistance. So far, it has not been clearly established whether all ceramides adversely affect the functioning of the insulin pathway, or whether there are certain ceramide species that play a pivotal role in the induction of insulin resistance. Therefore, we designed a study in which the expression of CerS1 and CerS5 genes responsible for the synthesis of C18:0-Cer and C16:0-Cer, respectively, was locally silenced in the gastrocnemius muscle of HFD-fed mice through in vivo electroporation-mediated shRNA plasmids. Our study indicates that HFD feeding induced both, the systemic and skeletal muscle insulin resistance, which was accompanied by an increase in the intramuscular lipid levels, decreased activation of the insulin pathway and, consequently, a decrease in the skeletal muscle glucose uptake. CerS1 silencing leads to a reduction in C18:0-Cer content, with a subsequent increase in the activity of the insulin pathway, and an improvement in skeletal muscle glucose uptake. Such effects were not visible in case of CerS5 silencing, which indicates that the accumulation of C18:0-Cer plays a decisive role in the induction of skeletal muscle insulin resistance.

Indexed as

Gene SilencingGlucoseInsulin ResistanceMembrane ProteinsMuscle, SkeletalSphingosine N-AcyltransferaseAcyl Coenzyme AAnimalsDiet, High-FatDiglyceridesFatty AcidsGenes, ReporterGreen Fluorescent ProteinsInsulinMaleMiceAcyl Coenzyme ACerS1 protein, mouseCers5 protein, mouseDiglyceridesFatty AcidsGlucoseGreen Fluorescent ProteinsInsulinMembrane ProteinsSphingolipidsSphingosine N-AcyltransferaseTrh4 protein, mouseceramidesgene silencinginsulin resistancemass spectrometryskeletal muscle

Identifiers

PMID35053322
PMCPMC8773817
OpenAlexW4205915405

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.